Skip to main content

RAST Type Tests: 2 Medicare contractor policies compared

2 Local Coverage Determinations in the current Medicare Coverage Database export carry the title "RAST Type Tests", between them covering 12 states and territories. 2 of them have a billing and coding article with a diagnosis list, ranging from 370 to 1,008 covered ICD-10-CM codes. 2 record a source policy it was derived from. The table below is the fastest way to see which version governs a given state and how far the versions have drifted.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Policies with this title
2
States covered
12
Versions with a coded article
2
Revision dates
2026-04-01 to 2026-07-30

Every version by contractor

Open a version for its full policy text, contracts, codes and related NCDs. Covered codes are the count of ICD-10-CM codes in the version's billing and coding article; a dash means the export attaches no coded article.

Local Coverage Determinations titled "RAST Type Tests"
LCDContractorStatesRevisedCovered codesPolicy words
L33591Wellpoint FederalCT IL MA ME MN NH NY RI VT WI2026-04-011,008229
L34063CGS Administrators, LLCKY OH2026-07-30370229

Lineage

The Medicare Coverage Database records the source policy a determination was derived from: L33591 from L28463; L34063 from L31894. A shared source explains why the opening paragraphs read alike; the revision dates and the diagnosis counts above show where the versions have since parted.

Which diagnoses each contractor covers

Across the 2 versions with a coded billing and coding article, 1,034 ICD-10-CM codes are covered by at least one contractor: 344 by every version and 690 (67%) by only some of them. L33591 (Wellpoint Federal) covers the most codes no other version lists (664). L34063 (CGS Administrators, LLC) leaves out the most codes that every other version covers (664), the version where a diagnosis accepted elsewhere is most often absent. The comparison is mechanical: it counts codes on the lists and does not weigh the policy text, frequency limits or documentation rules, which can matter as much as the list.

Unique codes appear on that version's covered list only; missing codes are covered by every other version but not by this one. Lists are the union of the coded billing and coding articles linked to each LCD (MCD release 2026-11-12).

Covered ICD-10-CM codes per version of RAST Type Tests
LCDContractorArticlesCoveredOnly hereMissing
L33591Wellpoint FederalA568441,00866426
L34063CGS Administrators, LLCA5704337026664

Where the lists part

Three-character ICD-10-CM categories ranked by how many of their codes are covered by some versions and not others; a category near the top is where checking the local list matters most.

ICD-10-CM categories with the most codes only some versions of RAST Type Tests cover
CategoryCategory title (FY2027)Codes that differ
T63Toxic effect of contact with venomous animals and plants281
T43Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified58
T50Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances36
T45Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified30
T78Adverse effects, not elsewhere classified30
T38Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified26
T40Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]23
T44Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system23
T46Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system23
T48Poisoning by, adverse effect of and underdosing of agents primarily acting on smooth and skeletal muscles and the respiratory system22
T36Poisoning by, adverse effect of and underdosing of systemic antibiotics21
T47Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system21

Code-by-contractor sample

100 of the 690 codes covered by some versions and not others, codes that most versions cover first and no more than three per category in the first pass. Y means the version's covered list includes the code.

100 of the 690 ICD-10-CM codes that only some versions of RAST Type Tests cover
ICD-10-CMDescription (FY2027)L33591L34063
L50.9Urticaria, unspecifiedY—
T36.0X5DAdverse effect of penicillins, subsequent encounterY—
T36.0X5SAdverse effect of penicillins, sequelaY—
T36.1X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounterY—
T36.1X5SAdverse effect of cephalosporins and other beta-lactam antibiotics, sequelaY—
T36.2X5DAdverse effect of chloramphenicol group, subsequent encounterY—
T36.2X5SAdverse effect of chloramphenicol group, sequelaY—
T36.3X5DAdverse effect of macrolides, subsequent encounterY—
T36.3X5SAdverse effect of macrolides, sequelaY—
T36.4X5DAdverse effect of tetracyclines, subsequent encounterY—
T36.4X5SAdverse effect of tetracyclines, sequelaY—
T36.5X5DAdverse effect of aminoglycosides, subsequent encounterY—
T36.5X5SAdverse effect of aminoglycosides, sequelaY—
T36.6X5DAdverse effect of rifampicins, subsequent encounterY—
T36.6X5SAdverse effect of rifampicins, sequelaY—
T36.7X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounterY—
T36.7X5SAdverse effect of antifungal antibiotics, systemically used, sequelaY—
T36.8X5DAdverse effect of other systemic antibiotics, subsequent encounterY—
T36.8X5SAdverse effect of other systemic antibiotics, sequelaY—
T36.95XAAdverse effect of unspecified systemic antibiotic, initial encounterY—
T36.95XDAdverse effect of unspecified systemic antibiotic, subsequent encounterY—
T36.95XSAdverse effect of unspecified systemic antibiotic, sequelaY—
T37.0X5DAdverse effect of sulfonamides, subsequent encounterY—
T37.0X5SAdverse effect of sulfonamides, sequelaY—
T37.1X5DAdverse effect of antimycobacterial drugs, subsequent encounterY—
T37.1X5SAdverse effect of antimycobacterial drugs, sequelaY—
T37.2X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounterY—
T37.2X5SAdverse effect of antimalarials and drugs acting on other blood protozoa, sequelaY—
T37.3X5DAdverse effect of other antiprotozoal drugs, subsequent encounterY—
T37.3X5SAdverse effect of other antiprotozoal drugs, sequelaY—
T37.4X5DAdverse effect of anthelminthics, subsequent encounterY—
T37.4X5SAdverse effect of anthelminthics, sequelaY—
T37.5X5DAdverse effect of antiviral drugs, subsequent encounterY—
T37.5X5SAdverse effect of antiviral drugs, sequelaY—
T37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounterY—
T37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequelaY—
T37.95XAAdverse effect of unspecified systemic anti-infective and antiparasitic, initial encounterY—
T37.95XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounterY—
T37.95XSAdverse effect of unspecified systemic anti-infective and antiparasitic, sequelaY—
T38.0X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounterY—
T38.0X5SAdverse effect of glucocorticoids and synthetic analogues, sequelaY—
T38.1X5DAdverse effect of thyroid hormones and substitutes, subsequent encounterY—
T38.1X5SAdverse effect of thyroid hormones and substitutes, sequelaY—
T38.2X5DAdverse effect of antithyroid drugs, subsequent encounterY—
T38.2X5SAdverse effect of antithyroid drugs, sequelaY—
T38.4X5DAdverse effect of oral contraceptives, subsequent encounterY—
T38.4X5SAdverse effect of oral contraceptives, sequelaY—
T38.5X5DAdverse effect of other estrogens and progestogens, subsequent encounterY—
T38.5X5SAdverse effect of other estrogens and progestogens, sequelaY—
T38.6X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounterY—
T38.6X5SAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequelaY—
T38.7X5DAdverse effect of androgens and anabolic congeners, subsequent encounterY—
T39.015DAdverse effect of aspirin, subsequent encounterY—
T39.015SAdverse effect of aspirin, sequelaY—
T39.095DAdverse effect of salicylates, subsequent encounterY—
T40.0X5DAdverse effect of opium, subsequent encounterY—
T40.0X5SAdverse effect of opium, sequelaY—
T40.2X5DAdverse effect of other opioids, subsequent encounterY—
T41.0X5DAdverse effect of inhaled anesthetics, subsequent encounterY—
T41.0X5SAdverse effect of inhaled anesthetics, sequelaY—
T41.1X5DAdverse effect of intravenous anesthetics, subsequent encounterY—
T42.0X5DAdverse effect of hydantoin derivatives, subsequent encounterY—
T42.0X5SAdverse effect of hydantoin derivatives, sequelaY—
T42.1X5DAdverse effect of iminostilbenes, subsequent encounterY—
T43.015DAdverse effect of tricyclic antidepressants, subsequent encounterY—
T43.015SAdverse effect of tricyclic antidepressants, sequelaY—
T43.025DAdverse effect of tetracyclic antidepressants, subsequent encounterY—
T44.0X5DAdverse effect of anticholinesterase agents, subsequent encounterY—
T44.0X5SAdverse effect of anticholinesterase agents, sequelaY—
T44.1X5DAdverse effect of other parasympathomimetics [cholinergics], subsequent encounterY—
T45.0X5DAdverse effect of antiallergic and antiemetic drugs, subsequent encounterY—
T45.0X5SAdverse effect of antiallergic and antiemetic drugs, sequelaY—
T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounterY—
T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounterY—
T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequelaY—
T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounterY—
T47.0X5DAdverse effect of histamine H2-receptor blockers, subsequent encounterY—
T47.0X5SAdverse effect of histamine H2-receptor blockers, sequelaY—
T47.1X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounterY—
T48.0X5DAdverse effect of oxytocic drugs, subsequent encounterY—
T48.0X5SAdverse effect of oxytocic drugs, sequelaY—
T48.1X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounterY—
T49.0X5DAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounterY—
T49.0X5SAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequelaY—
T49.1X5DAdverse effect of antipruritics, subsequent encounterY—
T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounterY—
T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequelaY—
T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounterY—
T63.011DToxic effect of rattlesnake venom, accidental (unintentional), subsequent encounterY—
T63.011SToxic effect of rattlesnake venom, accidental (unintentional), sequelaY—
T63.012DToxic effect of rattlesnake venom, intentional self-harm, subsequent encounterY—
T78.00XDAnaphylactic reaction due to unspecified food, subsequent encounterY—
T78.00XSAnaphylactic reaction due to unspecified food, sequelaY—
T78.01XDAnaphylactic reaction due to peanuts, subsequent encounterY—
T88.59XAOther complications of anesthesia, initial encounter—Y
T88.6XXDAnaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounterY—
T88.6XXSAnaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequelaY—
Z91.0111Allergy to milk products with tolerance to baked milk—Y
Z91.0112Allergy to milk products with reactivity to baked milk—Y
Z91.0120Allergy to eggs, unspecified—Y

Download every covered code with a column per LCD (CSV). The LCD coverage variation report ranks every multi-contractor title by how far its lists diverge.

How to use the comparison

Start from the state where the service is furnished and open that contractor's version; its billing and coding article carries the diagnosis codes the claims system will test. For a group that bills in several jurisdictions, the version with the smallest covered list is the safe common denominator for pre-service review, and the version with the largest list shows what documentation can support an appeal elsewhere. The L33591 version is the one most searched for this title; the LCD lookup guide explains how jurisdictions are assigned, and the LCD hub lists every topic that more than one contractor has written.

For teams evaluating QuickIntell software

Where QuickIntell fits across jurisdictions

For teams working across MAC jurisdictions, evaluate how requirements, source policies and documentation review should be organized for each case. Confirm jurisdiction-specific scope and supported actions during a QuickAuth evaluation; compare claim and denial follow-up separately in QuickRCM.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Why are there 2 LCDs called "RAST Type Tests"?

Each Medicare Administrative Contractor writes its own Local Coverage Determination for its jurisdiction. 2 contractors publish a policy with this title covering 12 states; they often start from one contractor's text and then revise separately, so dates, criteria and diagnosis lists differ by jurisdiction.

Which "RAST Type Tests" LCD applies to my claim?

The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished, or the DME MAC region for equipment. The table lists each policy's states; open the policy for that jurisdiction and its billing and coding article.

How different are the diagnosis lists?

Across the 2 versions with a coded billing and coding article, 1,034 ICD-10-CM codes are covered by at least one contractor: 344 by every version and 690 (67%) by only some of them. A diagnosis accepted under one contractor's version can deny under another's, so a group that bills in several jurisdictions checks the list of the contractor that processes each claim.

When were these policies last revised?

Revision effective dates run from 2026-04-01 to 2026-07-30. A claim is judged against the version in force on the date of service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.